Lv42
452 积分 2022-11-07 加入
The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
11小时前
已完结
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
20小时前
已完结
Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders
22小时前
已完结
Semaglutide reduces the risk of major kidney disease events in patients with type 2 diabetes
23小时前
求助中
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
23小时前
已完结
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
23小时前
已完结
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
17天前
已完结
The effect of shingles vaccination at different stages of the dementia disease course
30天前
已完结
ABNORMALITIES IN SMALL INTESTINE CONTOUR AND CALIBER
1个月前
已关闭
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
1个月前
已完结
皖公网安备34019202002308
